Cargando…
High-throughput genomic technology in research and clinical management of breast cancer. Plasma-based proteomics in early detection and therapy
Protein-based breast cancer biomarkers are a promising resource for breast cancer detection at the earliest and most treatable stages of the disease. Plasma is well suited to proteomic-based methods of biomarker discovery because it is easily obtained, is routinely used in the diagnosis of many dise...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1797031/ https://www.ncbi.nlm.nih.gov/pubmed/17184556 http://dx.doi.org/10.1186/bcr1619 |